Sera Prognostics, Inc.

NASDAQ:SERA

Medical - Diagnostics & Research

Healthcare
$1.91 -1.59%

-$0.03 today

Market cap
$74.11M
Beta
0.94
P/E (TTM)
-2.9
EPS (TTM)
-$0.64
52W Low $1.56High $4.09

Volume 0.01M

Average 0.06M

SERA Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Sera Prognostics, Inc.NASDAQ: SERA

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 50.26M shares rose 19.8% year over year, behind the +39.7% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +15.5% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +19.8% toward the trailing-twelve-month pace of +39.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
50.26M+0.6% QoQ
Last fiscal yearDec 2025
47.66M+43.7% YoY
LTMMar 2026
49.71M+39.7% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.8%——
1 year+43.7%——
3-year CAGR+15.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
47.66M USD
Year-over-year change
+43.7%
4-year CAGR
+11.6%

Weighted Avg Shares vs competitors

How SERA compares with its peers on the latest reported figures

  • SERA's LTM Mar 2026 weighted avg shares of 49.71M shares is the 5th highest of the 9 companies compared; the peer median is 47.8M shares.
  • Its year-over-year change of +39.7% is the 6th highest of 9, against a peer median of +76.0%.
  • Over three fiscal years its annual growth of +15.5% compares with a peer median of +38.6%.
SERA Competitors Peer median
Weighted Avg Shares for SERA and competitors
Company Period LTM YoY 3-year CAGR
LUCDLucid Diagnostics Inc.LTM Mar 2026102.76M +82.6%+41.3%
ONCYOncolytics Biotech Inc.LTM Mar 2026100.12M +27.6%+18.2%
CGTXCognition Therapeutics, Inc.LTM Mar 202679.93M +69.4%+35.9%
HURATuHURA Biosciences, Inc.LTM Mar 202650.79M +127.0%+911.7%
SERASera Prognostics, Inc.LTM Mar 202649.71M +39.7%+15.5%
RPIDRapid Micro Biosystems, Inc.LTM Mar 202644.81M +2.4%+1.7%
APYXApyx Medical CorporationLTM Mar 202641.45M +15.9%+6.9%
STSSSkyAI, Inc.LTM Mar 202630.8M +191004.4%+2642.4%
SRZNSurrozen, Inc.LTM Mar 20269.29M +179.8%+47.8%
Peer median (excluding SERA) 47.8M+76.0%+38.6%

Competitors are the stored peer set for SERA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue82K268K306K77K81K
Cost of Revenue37K193K210K82K164K
Gross Profit45K75K96K(5K)(83K)
Gross Margin54.9%28.0%31.4%-6.5%-102.5%
Research & Development11.02M14.24M15.23M14.73M13.17M
Selling, General & Admin24.42M31.48M24.69M21.9M23.25M
Operating Expenses35.44M45.73M39.92M36.63M36.42M
Depreciation & Amortization659K756K900K833K940K
EBITDA(33.6M)(43.37M)(35.29M)(32.04M)(30.98M)
EBITDA Margin-40980.5%-16182.5%-11531.7%-41606.5%-38245.7%
Operating Income(35.4M)(45.65M)(39.82M)(36.64M)(36.5M)
Operating Margin-43164.6%-17034.3%-13013.4%-47577.9%-45066.7%
Interest Income145K456K1.64M2.75M4.59M
Interest Expense746K61K55K28K9K
Other Income / Expenses386K1.47M3.58M3.74M4.58M
Income Before Tax(35.01M)(44.19M)(36.24M)(32.9M)(31.93M)
Pre-Tax Margin-42693.9%-16487.3%-11843.8%-42724.7%-39417.3%
Income Tax Expense00000
Net Income(35.01M)(44.19M)(36.24M)(32.9M)(31.93M)
Net Margin-42693.9%-16487.3%-11843.8%-42724.7%-39417.3%
EPS (Basic)(1.18)(1.43)(1.16)(0.99)(0.67)
EPS (Diluted)(1.18)(1.43)(1.16)(0.99)(0.67)
Weighted Avg Shares30.77M30.94M31.2M33.16M47.66M
Weighted Avg Shares (Diluted)30.77M30.94M31.2M33.16M47.66M

Sera Prognostics, Inc.

NASDAQ:SERA

Intrinsic Alpha fair value

Locked

Current Price

$1.91

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.